Candesartan cilexetil
Table of contents of the leaflet:
The name of the medicine is Carzap. The active substance of the medicine is candesartan cilexetil. It belongs to a group of medicines called angiotensin II receptor antagonists. It causes relaxation and dilation of blood vessels. This helps to lower blood pressure. The medicine also makes it easier for the heart to pump blood to all parts of the body.
Carzap is used:
In case of doubts about any of the above situations, the doctor or pharmacist should be consulted before taking Carzap.
Before starting to take Carzap, the doctor or pharmacist should be consulted:
The doctor may monitor kidney function, blood pressure, and electrolyte levels (e.g., potassium) in the blood at regular intervals.
See also the information under the heading "When not to take Carzap".
If any of the above conditions apply to the patient, the doctor may recommend more frequent checks and tests.
If the patient experiences abdominal pain, nausea, vomiting, or diarrhea after taking Carzap, they should discuss it with their doctor.
The doctor will decide on further treatment. The patient should not stop taking Carzap on their own.
If the patient is to undergo surgery, they should inform their doctor or dentist about taking Carzap. This is because Carzap, in combination with some anesthetics, may cause excessive lowering of blood pressure.
Studies have been conducted on the use of candesartan cilexetil in children. For further information, the doctor should be consulted. Carzap should not be given to children under 1 year of age due to the potential risk to kidney development.
The doctor or pharmacist should be told about all medicines the patient is taking or has recently taken, as well as any medicines the patient plans to take.
Carzap may affect the action of other medicines, and other medicines may affect Carzap. If the patient is taking certain medicines, the doctor may periodically recommend blood tests.
Particularly, the doctor should be informed if the patient is taking any of the following medicines:
The doctor may need to change the dose and/or take other precautions:
While taking Carzap, the doctor should be consulted if the patient plans to consume alcohol. Alcohol may cause dizziness or fainting.
Pregnancy
If the patient suspects they may be pregnant (or plans to have a child), they should consult their doctor. The doctor will usually recommend stopping Carzap before planned pregnancy or immediately after confirmation of pregnancy and recommend taking another medicine instead of Carzap. It is not recommended to take Carzap in early pregnancy and it should not be taken after 3 months of pregnancy, as it may seriously harm the fetus.
Breastfeeding
The doctor should be informed about breastfeeding or plans to breastfeed. It is not recommended to take Carzap during breastfeeding, especially in the case of breastfeeding a newborn or premature baby. The doctor may recommend taking another medicine.
While taking Carzap, some patients may feel tired and dizzy. If such symptoms occur, the patient should not drive vehicles, use tools, or operate machines.
Carzap contains lactose monohydrate, which is a type of sugar. If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking Carzap.
The medicinal product contains less than 1 mmol (23 mg) of sodium per tablet, which is considered "sodium-free".
This medicine should always be taken as directed by the doctor or pharmacist. In case of doubts, the doctor or pharmacist should be consulted .It is important to take Carzap every day.
Carzap can be taken with or without food.
The tablet should be swallowed with water.
Tablets should be taken daily at approximately the same time. This will help the patient remember to take the dose.
The recommended initial dose is 4 mg once daily.
Patients with a body weight <50 kg: in patients whose blood pressure is not adequately controlled, the doctor may decide to increase dose a maximum of 8 mg once daily.
Patients with a body weight ≥50 kg: in patients whose blood pressure is not adequately controlled, the doctor may decide to increase the dose to 8 mg once daily, and then to 16 mg once daily.
The recommended initial dose of Carzap is 4 mg once daily. The doctor may increase the dose by doubling it, at intervals of at least 2 weeks, to 32 mg once daily. Carzap can be taken with other medicines used to treat heart failure, and the doctor will decide which treatment is most suitable for the patient.
In case of taking a higher dose of Carzap than recommended by the doctor, the doctor or pharmacist should be contacted immediately.
A double dose should not be taken to make up for a missed dose. The next dose should be taken at the usual time.
If treatment with Carzap is stopped, blood pressure may rise again.
Therefore, Carzap should not be stopped without prior consultation with the doctor.
In case of any further doubts about taking this medicine, the doctor or pharmacist should be consulted .
Like all medicines, Carzap can cause side effects, although not everybody gets them.
It is important for the patient to know about the possibility of their occurrence.
Carzap may cause a decrease in the number of white blood cells. The patient's resistance to infection may be reduced, and they may experience fatigue, infection, or fever. If such symptoms occur, the doctor should be contacted. The doctor may recommend periodic blood tests to check if Carzap is affecting the blood (agranulocytosis).
Other possible side effects include:
In children treated for high blood pressure, side effects seem to be similar to those in adults, but they occur more frequently. A very common side effect in children, not reported in adults, is throat pain, and other side effects such as runny nose, fever, and rapid heartbeat in children occur frequently, while in adults they were not reported.
If the patient experiences any side effects, including those not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative in Poland.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister. The expiry date refers to the last day of the month.
There are no special precautions for storage of the medicinal product.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed .This will help protect the environment.
The active substance of the medicine is candesartan cilexetil.
Carzap, 8 mg, tablets: each tablet contains 8 mg of candesartan cilexetil.
Carzap, 16 mg, tablets: each tablet contains 16 mg of candesartan cilexetil.
Carzap, 32 mg, tablets: each tablet contains 32 mg of candesartan cilexetil.
The other ingredients are: lactose monohydrate, cornstarch, hydroxypropylcellulose (E 463), sodium croscarmellose (E 468), magnesium stearate (E 572), triethyl citrate (E 1505).
Carzap, 8 mg, are round, biconvex, white or almost white tablets with a score line on one side and the imprint C/8 on the same side. The diameter of the tablet is approximately 8 mm.
Carzap, 16 mg, are round, biconvex, white or almost white tablets with a score line on one side and the imprint C/16 on the same side. The diameter of the tablet is approximately 8 mm.
Carzap, 32 mg, are round, biconvex, white or almost white tablets with a score line on one side and the imprint C/32 on the same side. The diameter of the tablet is approximately 10.5 mm.
The tablet can be divided into equal doses.
Pack sizes: 7, 14, 28, 30, 56, 70, 90, 98 tablets.
Not all pack sizes may be marketed.
Zentiva k.s., U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic
Zentiva k.s. U kabelovny 130, Dolní Měcholupy, 102 37 Prague 10, Czech Republic
Bulgaria | КАРЗАП 16 mg |
Czech Republic | CARZAP |
Estonia | Carzan 16 (32) mg |
Lithuania | Carzan 8 (16) mg tablets |
Latvia | Carzan 8 (16; 32) mg tablets |
Poland | CARZAP |
Portugal | Candesartan Zentiva |
Zentiva Polska Sp. z o.o.
Bonifraterska 17 street
00-203 Warsaw
tel.: +48 22 375 92 00
Date of last revision of the leaflet:June 2025
Romania | CANZENO 8 (16; 32) mg tablets |
Slovakia | CARZAP 8 (16; 32) mg tablets |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.